| SpectraBase Spectrum ID |
DlkQkBk6LBo |
| Name |
DFMDA PR |
| Classification |
Amphetamine designer drug derivative |
| Comments |
Spectrum verified by independent measurements in external laboratories |
| Copyright |
Copyright © 2024 DigiLab GmbH and Wiley-VCH GmbH. All Rights Reserved. |
| Exact Mass |
257.122735115 u |
| Formula |
C13H17F2NO2 |
| InChI |
InChI=1S/C13H17F2NO2/c1-3-6-16-9(2)7-10-4-5-11-12(8-10)18-13(14,15)17-11/h4-5,8-9,16H,3,6-7H2,1-2H3 |
| InChIKey |
HXQNTATYLQJFMY-UHFFFAOYSA-N |
| Ionization Type |
Electron Ionization (EI) |
| Molecular Weight |
257.281 g/mol |
| Nominal Mass |
257 u |
| Quality |
995 |
| Retention Index |
1451 |
| SMILES |
C=12C(OC(O2)(F)F)=CC(CC(NCCC)C)=CC1 |
| SPLASH |
splash10-000i-9000000000-31a01b8ab1ab89eed83f |
| Source of Spectrum |
DigiLab GmbH (C) 2024 |
| Synonyms |
Amphetamine,N-propyl-3,4-(difluoromethylene)dioxy
N-Propyl-3,4-difluoromethylenedioxyamphetamine
N-[1-(2,2-Difluoro-2H-1,3-benzodioxol-5-yl)propan-2-yl]propan-1-amine |
| Technique |
GC/MS |
| Wiley ID |
DD2024_008197 |
